• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚产毒和非产毒艰难梭菌的高流行率。

High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

机构信息

School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia

Department of Microbiology, PathWest Laboratory Medicine, Nedlands, Australia.

出版信息

J Clin Microbiol. 2018 May 25;56(6). doi: 10.1128/JCM.00170-18. Print 2018 Jun.

DOI:10.1128/JCM.00170-18
PMID:29563206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5971540/
Abstract

Accumulating evidence shows a high prevalence of in Southeast Asia associated with a range of clinical presentations. However, severe infections are rarely reported. We investigated infection (CDI) across four hospitals in Kuala Lumpur and Kota Bharu, Malaysia. Enzyme immunoassays for glutamate dehydrogenase (GDH) and toxin A or B were performed on diarrheal stool specimens collected from patients in 2015 and 2016. Specimens were also cultured and isolates of characterized by PCR ribotyping and detection of toxin genes. In total, 437 specimens were collected and fecal toxin was detected in 3.0%. A further 16.2% of specimens were GDH positive and toxin negative. After culture, toxigenic strains were isolated from 10.3% and nontoxigenic strains from 12.4% of specimens. The most prevalent PCR ribotypes (RTs) were RT 017 (20.0%) and RT 043 (10.0%). The high prevalence of RT 017 and nontoxigenic strains in Malaysia and in neighboring Thailand and Indonesia suggests that they localize to the region of Southeast Asia, with an implication that they may mediate the burden of CDI in the region.

摘要

越来越多的证据表明,东南亚地区的发病率很高,与多种临床表现相关。然而,严重感染的病例却很少见。我们调查了马来西亚吉隆坡和哥打巴鲁的四家医院的艰难梭菌感染(CDI)情况。2015 年和 2016 年,我们收集了腹泻患者的粪便标本,并用酶联免疫吸附试验(GDH)和毒素 A 或 B 检测了这些标本。我们还对标本进行了培养,并通过 PCR 核糖体分型和毒素基因检测对 进行了鉴定。总共收集了 437 份标本,粪便毒素检测阳性率为 3.0%。进一步的检测发现,16.2%的标本 GDH 阳性而毒素阴性。经过培养,从 10.3%的标本中分离出了产毒菌株,从 12.4%的标本中分离出了非产毒菌株。最常见的 PCR 核糖体分型(RT)是 RT 017(20.0%)和 RT 043(10.0%)。马来西亚以及邻国泰国和印度尼西亚的 RT 017 和非产毒菌株的高流行率表明它们局限于东南亚地区,这意味着它们可能在该地区介导了 CDI 的负担。

相似文献

1
High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.马来西亚产毒和非产毒艰难梭菌的高流行率。
J Clin Microbiol. 2018 May 25;56(6). doi: 10.1128/JCM.00170-18. Print 2018 Jun.
2
Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of in a tertiary care hospital in Taif, Saudi Arabia.沙特阿拉伯塔伊夫一家三级医疗医院中[具体内容缺失]的患病率、毒素基因谱、基因型及抗生素敏感性
Indian J Med Microbiol. 2020 Apr-Jun;38(2):176-182. doi: 10.4103/ijmm.IJMM_20_300.
3
Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.马来西亚半岛东北部一家三级医院及老年社区中艰难梭菌感染与定植的患病率
Epidemiol Infect. 2017 Oct;145(14):3012-3019. doi: 10.1017/S0950268817002011. Epub 2017 Sep 11.
4
Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.优化台湾北部某医学中心艰难梭菌感染诊断的实验室工作流程。
J Microbiol Immunol Infect. 2021 Apr;54(2):284-289. doi: 10.1016/j.jmii.2019.08.004. Epub 2019 Sep 28.
5
High prevalence and diversity of tcdA-negative and tcdB-positive, and non-toxigenic, Clostridium difficile in Thailand.泰国产 tcdA 阴性 tcdB 阳性和非产毒艰难梭菌的高流行率和多样性。
Anaerobe. 2019 Jun;57:4-10. doi: 10.1016/j.anaerobe.2019.03.008. Epub 2019 Mar 9.
6
A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.两步算法结合谷氨酸脱氢酶和核酸扩增试验检测粪便标本中的艰难梭菌。
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):345-351. doi: 10.1007/s10096-020-04027-y. Epub 2020 Sep 18.
7
Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.毒素阳性和毒素阴性艰难梭菌标本中的定量粪便乳铁蛋白。
J Clin Microbiol. 2013 Jan;51(1):311-3. doi: 10.1128/JCM.02735-12. Epub 2012 Nov 7.
8
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.艰难梭菌相关性腹泻的实验室诊断及临床分离株的分子特征分析
New Microbiol. 2012 Jul;35(3):307-16. Epub 2012 Jun 30.
9
Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B.艰难梭菌的非产毒菌株缺乏毒素A和毒素B的基因。
J Clin Microbiol. 1991 Nov;29(11):2666-7. doi: 10.1128/jcm.29.11.2666-2667.1991.
10
Clostridium difficile infection in an Iranian hospital.伊朗一家医院的艰难梭菌感染
BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.

引用本文的文献

1
() infection in hospitalized adult patients in Cambodia.柬埔寨住院成年患者中的()感染。
Microbiol Spectr. 2025 Apr;13(4):e0274724. doi: 10.1128/spectrum.02747-24. Epub 2025 Feb 19.
2
A quantitative PCR to detect non-toxigenic .一种用于检测非产毒型的定量聚合酶链反应。
Microbiol Spectr. 2025 Jan 7;13(1):e0160824. doi: 10.1128/spectrum.01608-24. Epub 2024 Dec 11.
3
Prevalence of Non-Toxigenic in Diarrhoea Patients and Their Clinical Characteristics.腹泻患者中非产毒型的患病率及其临床特征。
Antibiotics (Basel). 2023 Aug 24;12(9):1360. doi: 10.3390/antibiotics12091360.
4
Sentinel surveillance and epidemiology of in Denmark, 2016 to 2019.丹麦 2016 至 2019 年 监测和流行病学研究
Euro Surveill. 2022 Dec;27(49). doi: 10.2807/1560-7917.ES.2022.27.49.2200244.
5
Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.东南亚艰难梭菌感染的流行病学
Am J Trop Med Hyg. 2022 Aug 8;107(3):517-26. doi: 10.4269/ajtmh.21-1167.
6
The Current Knowledge on Infection in Patients with Inflammatory Bowel Diseases.关于炎症性肠病患者感染的当前知识
Pathogens. 2022 Jul 21;11(7):819. doi: 10.3390/pathogens11070819.
7
Global evolutionary dynamics and resistome analysis of ribotype 017.核糖体分型017的全球进化动力学及耐药基因组分析
Microb Genom. 2022 Mar;8(3). doi: 10.1099/mgen.0.000792.
8
Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand.轻度或恶性:泰国艰难梭菌感染的临床特征与结局
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01217-20.
9
ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.2004 年至 2018 年,ribotypes 001 和 126 在德黑兰医疗保健环境中占主导地位:一项长达 14 年的横断面研究。
Emerg Microbes Infect. 2020 Dec;9(1):1432-1443. doi: 10.1080/22221751.2020.1780949.
10
Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.2014 年和 2015 年来自亚太地区 12 个国家的艰难梭菌分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00296-20.

本文引用的文献

1
A current perspective on antimicrobial resistance in Southeast Asia.东南亚地区抗菌药物耐药性的现状分析。
J Antimicrob Chemother. 2017 Nov 1;72(11):2963-2972. doi: 10.1093/jac/dkx260.
2
Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.马来西亚半岛东北部一家三级医院及老年社区中艰难梭菌感染与定植的患病率
Epidemiol Infect. 2017 Oct;145(14):3012-3019. doi: 10.1017/S0950268817002011. Epub 2017 Sep 11.
3
Prevalence and molecular epidemiology of infection in Indonesia.印度尼西亚感染的流行情况及分子流行病学
New Microbes New Infect. 2017 May 4;18:34-37. doi: 10.1016/j.nmni.2017.04.006. eCollection 2017 Jul.
4
Prevalence and molecular epidemiology of infection in Thailand.泰国感染的患病率及分子流行病学
New Microbes New Infect. 2016 Oct 21;15:27-32. doi: 10.1016/j.nmni.2016.10.004. eCollection 2017 Jan.
5
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.艰难梭菌毒素变异株PCR核糖体分型017的比较基因组分析及全球系统发育研究揭示了两个独立亚谱系的进化过程。
J Clin Microbiol. 2017 Mar;55(3):865-876. doi: 10.1128/JCM.01296-16. Epub 2016 Dec 28.
6
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.欧洲临床微生物学和传染病学会:艰难梭菌感染诊断指南文件的更新。
Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81. doi: 10.1016/j.cmi.2016.03.010. Epub 2016 Jul 25.
7
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.社区相关性艰难梭菌感染的流行病学和危险因素:一篇叙述性综述。
Infect Dis Ther. 2016 Sep;5(3):231-51. doi: 10.1007/s40121-016-0117-y. Epub 2016 Jul 1.
8
Routine detection of Clostridium difficile in Western Australia.西澳大利亚艰难梭菌的常规检测
Anaerobe. 2016 Feb;37:34-7. doi: 10.1016/j.anaerobe.2015.11.007. Epub 2015 Nov 22.
9
Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand.泰国一家大型教学医院艰难梭菌感染的分子流行病学
PLoS One. 2015 May 22;10(5):e0127026. doi: 10.1371/journal.pone.0127026. eCollection 2015.
10
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.非产毒艰难梭菌 M3 菌株孢子给药预防复发性艰难梭菌感染:一项随机临床试验。
JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.